Colourful i-Base graphic. The main text reads: Homophobic and transphobic attacks and discrimination continue in Uganda. At the top is i-Base’s website address: I hyphen base dot info. A smaller rectangle in the bottom right, reads: HIV news. 2026. There are various dotted patterns. The colours used in the image are two shades of dark grey-blue, dark purple, light blue, pink, mint green, turquoise, orange, dark green, mustard and white.

Assaults continue on #LGBTQI people in #Uganda.

@hrapfuganda.bsky.social’s report has the latest cases, including violent attacks or threats, evictions, police entrapment, extortion & discrimination in healthcare settings.

Examples here – these may be distressing:
i-base.info/htb/53403

#AHA23

On April 3rd April 2024, Uganda’s Constitutional Court delivered judgement in the consolidated petitions challenging the #AHA23 substantially upholding the law.

As #AHA23 enters its second year of implementation, here is a look at what it actually provides for following the judgement ⬇️⬇️

Final AZALEA-TIMI 71 results confirm #AHA23 buzz: abelacimab ↓major/clinically relevant nonmajor bleeding compared w/rivaroxaban in patients w/AF and mod-to-high stroke risk. However, we must wait for Ph3 data to understand effects on stroke prevention. #Medsky #Cardiosky #Cardiology

11) Need an #AZALEA refresher? You can still earn credit by reviewing our live #tweeetorial from #AHA23 at cardiometabolic-ce.com/antithrombot.... AZALEA was a Ph 2 comparison of #abelacimab vs #rivaroxaban in pts w/#AF + mod/high risk of #stroke.

Always fun to write for the @hnetbookchannel.bsky.social!

This piece drew on the #AHA23 and #AHA24 op-ed workshops, including advice given by @profgabriele.com, @jennholland.bsky.social, Felicia Viator, and Jim Grossman at this year's event.

@WomenHeartOrg staff, @Dr_Eileen_Hsich & @NanetteWenger met to plan next steps to support women on their ♥️disease journey, advocate for equity and find cures. #AHA23

On now, moderating an amazing KCVD oral abstract session at #AHA23

The Cardiovascular-Kidney Paradigm: Vessels, Valves, and Beyond

Come by 116 to hear about these exciting new findings!

Giving a talk on AI for precision phenotyping this morning at #AHA23

📢New in JAMA

Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a): A Randomized Dose-Ascending Clinical Trial
ja.ma/3SCSHQW
#MedSky

Presented today at #AHA23

The landscape of lipoprotein treatment is rapidly expanding! Despite this, there are barriers with regard to adherence, access and prescribing that hinder implementation.

-Bruce Warden, PharmD #AHA23 @AHAMeetings

A very fine day @ #AHA23. Friends, @AHAScience, celebrations.

📢New in JAMA & presented #AHA23

Effect of Dietary Sodium on Blood Pressure: A Crossover Trial jamanetwork.com/journals/jam...
#MedSky

“..dietary sodium reduction was comparable with a commonly used first-line antihypertensive medication” HCTZ 12.5 mg

📢New in JAMA

Long-Term Blood Pressure Control After Hypertensive Pregnancy Following Physician-Optimized Self-Management: The POP-HT Randomized Clinical Trial jamanetwork.com/journals/jam...

Presented & Published today #AHA23 #MedSky

📢NEW in JAMA

Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial

Presented & published today #AHA23 #MedSky jamanetwork.com/journals/jam...

Wegovy cuts risk of heart attacks in milestone cardiovascular trial Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a landmark cardiovascular trial that affirms the treatment offers health benefits beyond weight loss.

BREAKING at #AHA23: SELECT full results are out -- showing that Wegovy notably cut the rate of heart attacks, driving overall cardiovascular risk reduction

Read our paper here –www.ahajournals.org/doi/abs/10.1161/CIRCULAT...

And if you will be at #AHA23, come visit the poster session on Monday, Nov 13, 10:00-11.30 am, Zone 2.

eppro01.ativ.me/src/EventPil...

Have you ever wondered whether your patient with CAD and cardiomyopathy truly has ischemic cardiomyopathy, or whether the CAD is a “bystander”?

You might be interested in our paper now out in Circulation

#simultaneouspublication
#AHA23
#cardiosky
#Medsky
#WhyCMR

Starting off #AHA23 as a panelist in an exciting session on Critical Care Cardiology Meets Nephrology. Learning more nuances of renal physiology at a cardiology conference from @RangaswJ 🤩🥰

Nerded out @RdgTerminalMkt this morning and indulged in one of these beautiful dark chocolate hearts in honor of #AHA23 #Philadelphia @AHAMeetings